US Patent Issued to Abbott Diabetes Care on Aug. 12 for "Noise rejection methods and apparatus for sparsely sampled analyte sensor data" (California Inventor)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,383,164, issued on Aug. 12, was assigned to Abbott Diabetes Care Inc. (Alameda, Calif.).

"Noise rejection methods and apparatus for sparsely sampled analyte sensor data" was invented by Erwin Satrya Budiman (Fremont, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Systems, methods and apparatus are provided for rejecting noise from sparsely sampled analyte sensor data. Embodiments of the present disclosure include receiving a raw set of sensor data from an on-body device including an in vivo analyte sensor, determining an interpolation-based estimate of an analyte level over time based on the raw set of sensor data, determining an extrapolation-ba...